Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
Bachmeyer
Claude
C
Cadranel
Jean-François
JF
Demontis
Renato
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000075202:Contraindications; D003520:Cyclophosphamide; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide